BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8859196)

  • 21. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
    Isogai R; Fukao M; Kawada A
    J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
    López-Guillermo A; García-Conde J; Alvarez-Carmona AM; León P; Maldonado J; Alcalá A; Zubizarreta A; Sancho-Tello R; Carbonell F; Contreras E; Besses C; Hernando A; Fontanillas M; Montserrat E
    Med Clin (Barc); 1998 May; 110(16):601-4. PubMed ID: 9656196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors in low-grade lymphoma].
    Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
    Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
    Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
    Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
    Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
    J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
    Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
    Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
    J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
    Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis.
    Ferry JA; Sklar J; Zukerberg LR; Harris NL
    Am J Surg Pathol; 1991 Mar; 15(3):268-79. PubMed ID: 1996731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases.
    Rubie H; Gladieff L; Robert A; Gaubert I; Huguet F; Rochaix P; Pein F; Michel G; Hoerni B; Sommelet D
    Med Pediatr Oncol; 1994; 22(3):155-61. PubMed ID: 8272005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small cell variant of anaplastic large cell lymphoma diagnosed by a novel chromosomal abnormality t(2;5;3)(p23;q35;p21) of bone marrow cells.
    Sano F; Tasaka T; Nishimura H; Akiyama T; Kubo Y; Matsuhashi Y; Wada H; Sugihara T; Sadahira Y
    Pathol Int; 2008 Aug; 58(8):494-7. PubMed ID: 18705769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ki-1-positive anaplastic large-cell lymphoma can mimic benign dermatoses.
    Camisa C; Helm TN; Sexton C; Tuthill R
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):696-700. PubMed ID: 8227541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage IE non-Hodgkin's lymphoma involving the dura: A clinicopathologic study of five cases.
    Miranda RN; Glantz LK; Myint MA; Levy N; Jackson CL; Rhodes CH; Glantz MJ; Medeiros LJ
    Arch Pathol Lab Med; 1996 Mar; 120(3):254-60. PubMed ID: 8629900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous intravascular anaplastic large cell lymphoma.
    Wang L; Li C; Gao T
    J Cutan Pathol; 2011 Feb; 38(2):221-6. PubMed ID: 20337769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ki-1-positive anaplastic large cell lymphoma: a morphologic and immunologic study of 14 cases.
    Biernat W
    Pol J Pathol; 1994; 45(1):39-44. PubMed ID: 7513846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic large cell lymphoma of the ovary in a pediatric patient.
    Chong AL; Ngan BY; Weitzman S; Abla O
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):702-4. PubMed ID: 19684523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature.
    Onciu M; Behm FG; Raimondi SC; Moore S; Harwood EL; Pui CH; Sandlund JT
    Am J Clin Pathol; 2003 Oct; 120(4):617-25. PubMed ID: 14560573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CD30 (Ki-1+) anaplastic large cell lymphomas].
    Bagot M; Wechsler J; Cosnes A; Haioun C; Divine M; Gaulard P; Henni T; Revuz J
    Ann Dermatol Venereol; 1989; 116(11):881-3. PubMed ID: 2482686
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma.
    Herrera E; Gallardo M; Bosch R; Cabra B; Aneri V; Sánchez P
    J Cutan Pathol; 2002 Mar; 29(3):181-4. PubMed ID: 11972717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.